https://www.miragenews.com/car-t-cell-therapy-shows-promise-in-aggressive-1189756/
https://www.nature.com/articles/s41591-024-02875-1?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news
Results from another phase 1 study from the the city of hope and our very own Christine Brown.
Looks like their response rate and overall survival rate was very similar to our early phase 1a data.
I dare say when we find the dose sweet spot and start dosing patients in the 2nd line of treatment, as opposed to the later lines, we'll improve upon both response and survival.
Important to remember also "Chlorotoxin in the hands of city of hope has bound to the glioblastomas of more patients and more cells within those patients than any other agent they've tried."
- Forums
- ASX - By Stock
- CHM
- Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial, page-75
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.951M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.0¢ | $38.54K | 3.639M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 2646760 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 729690 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 2646760 | 0.010 |
17 | 5662631 | 0.009 |
19 | 6301003 | 0.008 |
12 | 5691427 | 0.007 |
7 | 2844766 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 600000 | 1 |
0.012 | 367088 | 3 |
0.013 | 453846 | 2 |
0.014 | 705016 | 3 |
0.015 | 579596 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online